MMP-9 in atrial remodeling in patients with atrial fibrillation

Annales de Cardiologie et d'Angeiologie - Tập 64 - Trang 285-291 - 2015
J. Lewkowicz1, M. Knapp2, A. Tankiewicz-Kwedlo3, R. Sawicki2, M. Kamińska2, E. Waszkiewicz2, W.J. Musiał2
1Department of Cardiosurgery, Medical University of Białystok, ul. M. Skłodowskiej-Cure 24a, 15-276, Białystok, Poland
2Department of Cardiology, Medical University of Białystok, Białystok, Poland
3Department of Monitored Pharmacotherapy, Medical University of Białystok, Białystok, Poland

Tài liệu tham khảo

van den Berg, 2002, Impact of atrial fibrillation on mortality in patients with chronic heart failure, Eur J Heart Fail, 4, 571, 10.1016/S1388-9842(02)00094-6

Ahmed, 2004, Impact of atrial fibrillation on mortality and readmission in older adults hospitalized with heart failure, Eur J Heart Fail, 6, 421, 10.1016/j.ejheart.2003.11.011

Stewart, 2004, Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK, Heart, 90, 286, 10.1136/hrt.2002.008748

Pellman, 2010, Extracellular matrix remodeling in atrial fibrosis: mechanisms and implications in atrial fibrillation, J Mol Cell Cardiol, 48, 461, 10.1016/j.yjmcc.2009.09.001

Xu, 2004, Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation, Circulation, 109, 363, 10.1161/01.CIR.0000109495.02213.52

Mukherjee, 2006, Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation, Am J Cardiol, 97, 532, 10.1016/j.amjcard.2005.08.073

Okumura, 2007, Extracellular matrix remodeling as a cause of persistent atrial fibrillation: another therapeutic target, J Cardiovasc Electrophysiol, 18, 1083, 10.1111/j.1540-8167.2007.00918.x

Kassiri, 2005, Myocardial extra-cellular matrix and its regulation by metalloproteinases and their inhibitors, Thromb Haemost, 93, 212, 10.1160/TH04-08-0522

European Heart Rhythm Association, 2010, ESC Committee for Practice Guidelines. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC), Europace, 12, 1360

Wijffels, 1995, Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats, Circulation, 92, 1954, 10.1161/01.CIR.92.7.1954

Ausma, 2001, Time course of atrial fibrillation-induced cellular structural remodeling in atria of the goat, J Mol Cell Cardiol, 33, 2083, 10.1006/jmcc.2001.1472

Shinagawa, 2002, Dynamic nature of atrial fibrillation substrate during development and reversal of heart failure in dogs, Circulation, 105, 2672, 10.1161/01.CIR.0000016826.62813.F5

Miyauchi, 2003, Altered atrial electrical restitution and heterogeneous sympathetic hyperinnervation in hearts with chronic left ventricular myocardial infarction: implications for atrial fibrillation, Circulation, 108, 360, 10.1161/01.CIR.0000080327.32573.7C

Tanaka, 2007, Spatial distribution of fibrosis governs fibrillation wave dynamics in the posterior left atrium during heart failure, Circ Res, 101, 839, 10.1161/CIRCRESAHA.107.153858

Kostin, 2002, Structural correlate of atrial fibrillation in human patients, Cardiovasc Res, 54, 361, 10.1016/S0008-6363(02)00273-0

Shiroshita-Takeshita, 2005, Atrial fibrillation: basic mechanisms, remodeling and triggers, J Interv Card Electrophysiol, 13, 181, 10.1007/s10840-005-2362-y

Nattel, 2002, New ideas about atrial fibrillation 50 years on, Nature, 415, 219, 10.1038/415219a

Spinale, 2007, Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function, Physiol Rev, 87, 1285, 10.1152/physrev.00012.2007

Bajraktari, 2012, Plasma metalloproteinase-9 and restrictive filling pattern as major predictors of outcome in patients with ischemic cardiomyopathy, Eur J Intern Med, 23, 616, 10.1016/j.ejim.2012.04.013

Kelly, 2008, Plasma tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9: novel indicators of left ventricular remodelling and prognosis after acute myocardial infarction, Eur Heart J, 29, 2116, 10.1093/eurheartj/ehn315

Buralli, 2010, Circulating matrix metalloproteinase-3 and metalloproteinase-9 and tissue Doppler measures of diastolic dysfunction to risk stratify patients with systolic heart failure, Am J Cardiol, 105, 853, 10.1016/j.amjcard.2009.11.038

Dini, 2010, Plasma matrix metalloproteinase-9 better predicts outcome than N-terminal protype-B natriuretic peptide in patients with systolic heart failure and a high prevalence of coronary artery disease, Biomed Pharmacother, 64, 339, 10.1016/j.biopha.2009.09.008

Zhu, 2011, Differential gene expression during atrial structural remodeling in human left and right atrial appendages in atrial fibrillation, Acta Biochim Biophys Sin, 43, 535, 10.1093/abbs/gmr046

Nakano, 2004, Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation, J Am Coll Cardiol, 43, 818, 10.1016/j.jacc.2003.08.060

Moe, 2008, Matrix metalloproteinase inhibition attenuates atrial remodeling and vulnerability to atrial fibrillation in a canine model of heart failure, J Card Fail, 14, 768, 10.1016/j.cardfail.2008.07.229

Chen, 2008, Upregulation of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases in rapid atrial pacing-induced atrial fibrillation, J Mol Cell Cardiol, 45, 742, 10.1016/j.yjmcc.2008.07.007

Anné, 2005, Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation, Cardiovasc Res, 67, 655, 10.1016/j.cardiores.2005.04.016

Kato, 2009, Impact of matrix metalloproteinase-2 levels on long-term outcome following pharmacological or electrical cardioversion in patients with atrial fibrillation, Europace, 11, 332, 10.1093/europace/eun389

Kalogeropoulos, 2011, Novel association patterns of cardiac remodeling markers in patients with essential hypertension and atrial fibrillation, BMC Cardiovasc Disord, 11, 77, 10.1186/1471-2261-11-77

Kelly, 2007, Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study, Eur Heart J, 28, 711, 10.1093/eurheartj/ehm003

Szulik, 2011, Echocardiography-based qualification and response assessment to cardiac resynchronisation therapy in patients with chronic heart failure. The matrix metalloproteinase-9 substudy, Kardiol Pol, 69, 1043

Spinale, 2002, Matrix metalloproteinases: regulation and dysregulation in the failing heart, Circ Res, 90, 520, 10.1161/01.RES.0000013290.12884.A3

Gramley, 2007, Decreased plasminogen activator inhibitor and tissue metalloproteinase inhibitor expression may promote increased metalloproteinase activity with increasing duration of human atrial fibrillation, J Cardiovasc Electrophysiol, 18, 1076, 10.1111/j.1540-8167.2007.00906.x

Thông tin
Thông tin xuất bản

Annales de Cardiologie et d'Angeiologie

Tập 64

285-291

Thông tin tác giả